BankPlus Trust Department bought a new stake in The Clorox Company (NYSE:CLX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm bought 245 shares of the company’s stock, valued at approximately $40,000.
Other large investors also recently made changes to their positions in the company. Catalyst Capital Advisors LLC acquired a new stake in shares of Clorox in the 3rd quarter valued at about $54,000. Los Angeles Capital Management LLC grew its stake in shares of Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after buying an additional 10,149 shares during the period. Advisors Asset Management Inc. grew its stake in shares of Clorox by 43.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after buying an additional 9,037 shares during the period. Natixis Advisors LLC boosted its stake in Clorox by 8.3% during the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after purchasing an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after purchasing an additional 13,038 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox Trading Up 1.5 %
NYSE:CLX opened at $157.00 on Wednesday. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market capitalization of $19.34 billion, a PE ratio of 42.90, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The firm’s 50 day moving average is $157.40 and its 200 day moving average is $160.13. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.11%. Clorox’s payout ratio is 133.33%.
Analyst Ratings Changes
A number of equities analysts have issued reports on the company. JPMorgan Chase & Co. lifted their price target on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Wells Fargo & Company lifted their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Barclays lifted their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, Evercore ISI boosted their target price on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $158.21.
View Our Latest Stock Analysis on CLX
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- How to Calculate Inflation Rate
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Business Services Stocks Investing
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.